Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00478491 · ClinicalTrials.gov registry record
fMRI of Vulnerable Brain Regions in Persons at Risk for Alzheimer's Disease
A clinical trial of Dementia and Alzheimers Disease, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- 390
- Enrollment target
- 1
- Study location
NCT00478491 is a study of Dementia and Alzheimers Disease that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 390 participants, below the 7,721-participant average among 199 other Dementia trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00478491, a study of Dementia and Alzheimers Disease, has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- 390 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to investigate the organization of memory and develop future methods for early detection of AD. Using functional magnetic resonance imaging (fMRI), we examine the responsiveness of the brain to memory tasks, specifically focusing on regions of the brain (the mesial temporal lobe and posterior cingulate) that are known to be involved in early stages of Alzheimer's disease (AD). Of interest are differences in brain activation between people with and without a family history of AD and other risk factors.
Conditions Studied
Study Locations (1)
Wisconsin
- University of Wisconsin - Wisconsin Comprehensive Memory Program - Madison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 390 participants |
| Start Date | 2003-01 |
| Est. Completion | 2011-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00478491
The ClinicalTrials.gov registry entry for NCT00478491 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 390 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 7,721-participant average among 199 other Dementia trials with a reported enrollment target (95% lower). The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Dementia appearing as the primary indexed condition, and to 0 interventions.
NCT00478491 reports 1 study location spanning 1 distinct geographic area - top geographies include Wisconsin.
Frequently Asked Questions
What is clinical trial NCT00478491 about?
NCT00478491 is a clinical study titled "fMRI of Vulnerable Brain Regions in Persons at Risk for Alzheimer's Disease". The purpose of this study is to investigate the organization of memory and develop future methods for early detection of AD. Using functional magnetic resonance imaging (fMRI), we examine the responsiveness of the brain to memory tasks, specifically focusing on regions of the brain (the mesial tempo...
What is the current status of trial NCT00478491?
This trial is currently completed. The enrollment target is 390 participants. The study started on 2003-01. Estimated completion is 2011-07.
What conditions does trial NCT00478491 study?
This clinical trial studies the following conditions: Dementia, Alzheimers Disease, Magnetic Resonance Imaging, Adult Children, Risk.
Who is sponsoring clinical trial NCT00478491?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00478491 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dementia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Dynamic Light Scattering Ocular Measurement in the Detection of Dementia
RECRUITING
-
Ferritin and Iron Burden in SAH sIRB
RECRUITING · Phase 1
-
δ in Dementia Clinical Trials
RECRUITING · NA
-
Door-Through-Door Companion Rideshare Technology for Individuals With Alzheimer's Disease and Related Dementias (AD/ADRD)
RECRUITING · Phase 1
-
Caregiver as Navigator: Develop Skills Online (CAN-DO)
RECRUITING · NA
-
Clinical Trial Evaluating the Efficacy of AGB101 for Reducing Hippocampal Overactivity in Older Adults
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.